{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:08Z","timestamp":1791357188874,"version":"4.3.1"},"reference-count":57,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:p>OBJECTIVES. The purpose of this work was to assess the effect of botulinum toxin A and occupational therapy compared with occupational therapy alone on body structure, activities participation, and self-perception in a sample of children (aged 3\u201316 years) with hemiplegic cerebral palsy recruited from a statewide register.<\/jats:p>\n               <jats:p>PATIENTS AND METHODS. Participants of this single-blind, randomized, controlled trial identified from a population-based cerebral palsy register received either an individually prescribed and localized injection of botulinum toxin A with 4 sessions of occupational therapy over 4 weeks (intervention) or occupational therapy alone (control). Outcomes were assessed from 2 domains of the World Health Organization International Classification of Functioning, Disability, and Health: body structure (Modified Ashworth Scale and Tardieu Scale) and activities participation (Assessment of Motor and Process Skills, Goal Attainment Scale, Pediatric Evaluation of Disability Inventory, and Pediatric Quality of Life Inventory). Self-perception was also measured.<\/jats:p>\n               <jats:p>RESULTS. All of the participants (intervention: n = 21; control: n = 22) provided data at baseline and 3 and 6 months. Mean age was 8.6 years; 23 were boys and 20 were girls. At 3 months, children allocated to receive the intervention performed significantly better in terms of body structure and activities participation. They reported improvements in self-perception for the global self-worth domain. At 6 months, the differences between the intervention and control groups persisted for the measures of body structure but not for activities participation or self-perception.<\/jats:p>\n               <jats:p>CONCLUSION. Botulinum toxin A injection combined with a low-intensity occupational therapy program achieves significant improvements in body structure, activity participation, and self-perception.<\/jats:p>","DOI":"10.1542\/peds.2006-2425","type":"journal-article","created":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T16:31:35Z","timestamp":1177432295000},"page":"e1149-e1158","source":"Crossref","is-referenced-by-count":87,"title":["Upper-Limb Botulinum Toxin A Injection and Occupational Therapy in Children With Hemiplegic Cerebral Palsy Identified From a Population Register: A Single-Blind, Randomized, Controlled Trial"],"prefix":"10.1542","volume":"119","author":[{"given":"Remo N.","family":"Russo","sequence":"first","affiliation":[{"name":"Flinders University Department of Rehabilitation and Aged Care, Repatriation General Hospital, Daw Park, South Australia, Australia;"},{"name":"Department of Child and Adolescent Development and Rehabilitation"},{"name":"Novita Children's Services, Regency Park, South Australia, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Crotty","sequence":"additional","affiliation":[{"name":"Flinders University Department of Rehabilitation and Aged Care, Repatriation General Hospital, Daw Park, South Australia, Australia;"},{"name":"Flinders Centre for Clinical Change and Health Care Research, Flinders University, Bedford Park, South Australia, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Miller","sequence":"additional","affiliation":[{"name":"Flinders Centre for Clinical Change and Health Care Research, Flinders University, Bedford Park, South Australia, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Murchland","sequence":"additional","affiliation":[{"name":"Novita Children's Services, Regency Park, South Australia, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Flett","sequence":"additional","affiliation":[{"name":"Royal Hobart Hospital, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Haan","sequence":"additional","affiliation":[{"name":"South Australian Clinical Genetics Service, Women's and Children's Hospital, North Adelaide, South Australia, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,5,1]]},"reference":[{"key":"2021120823344016900_R1","doi-asserted-by":"crossref","unstructured":"Taft LT. Cerebral palsy. Pediatr Rev.\u20081995;16:411\u2013418","DOI":"10.1542\/pir.16-11-411"},{"key":"2021120823344016900_R2","doi-asserted-by":"crossref","unstructured":"Bax M, Goldstein M, Rosenbaum P, et al. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol.\u20082005;47:571\u2013576","DOI":"10.1017\/S001216220500112X"},{"key":"2021120823344016900_R3","doi-asserted-by":"crossref","unstructured":"Reddihough DS, Collins KJ. The epidemiology and causes of cerebral palsy. Aust J Physiother.\u20082003;49:7\u201312","DOI":"10.1016\/S0004-9514(14)60183-5"},{"key":"2021120823344016900_R4","doi-asserted-by":"crossref","unstructured":"Graham HK. Botulinum toxin A in cerebral palsy: functional outcomes. J Pediatr.\u20082000;137:300\u2013303","DOI":"10.1067\/mpd.2000.109107"},{"key":"2021120823344016900_R5","doi-asserted-by":"crossref","unstructured":"Surman G, Bonellie S, Chalmers J, et al. UKCP: a collaborative network of cerebral palsy registers in the United Kingdom. J Public Health (Oxf).\u20082006;28:148\u2013156","DOI":"10.1093\/pubmed\/fdi087"},{"key":"2021120823344016900_R6","doi-asserted-by":"crossref","unstructured":"Uvebrant P. Hemiplegic cerebral palsy. Aetiology and outcome. Acta Paediatr Scand.\u20081988;345(suppl):1\u2013100","DOI":"10.1111\/j.1651-2227.1988.tb14939.x"},{"key":"2021120823344016900_R7","doi-asserted-by":"crossref","unstructured":"Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur J Neurol.\u20082001;8(suppl 5):150\u2013166","DOI":"10.1046\/j.1468-1331.2001.00048.x"},{"key":"2021120823344016900_R8","doi-asserted-by":"crossref","unstructured":"Beckung E, Hagberg G. Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev Med Child Neurol.\u20082002;44:309\u2013316","DOI":"10.1111\/j.1469-8749.2002.tb00816.x"},{"key":"2021120823344016900_R9","doi-asserted-by":"crossref","unstructured":"Van Zelst BR, Miller MD, Russo R, Murchland S, Crotty M. Evidence for activity and participation restriction in children with hemiplegic cerebral palsy: a cross-sectional evaluation using the Assessment of Motor and Process Skills in a familiar home environment. Dev Med Child Neurol.\u20082006;48:723\u2013727","DOI":"10.1017\/S0012162206001551"},{"key":"2021120823344016900_R10","doi-asserted-by":"crossref","unstructured":"Shields N, Murdoch A, Loy Y, Dodd KJ, Taylor NF. A systematic review of the self-concept of children with cerebral palsy compared with children without disability. Dev Med Child Neurol.\u20082006;48:151\u2013157","DOI":"10.1017\/S0012162206000326"},{"key":"2021120823344016900_R11","doi-asserted-by":"crossref","unstructured":"Autti-Ramo I, Larsen A, Taimo A, von Wendt L. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications. Eur J Neurol.\u20082001;8(suppl 5):136\u2013144","DOI":"10.1046\/j.1468-1331.2001.00046.x"},{"key":"2021120823344016900_R12","doi-asserted-by":"crossref","unstructured":"Friedman A, Diamond M, Johnston MV, Daffner C. Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy. Am J Phys Med Rehabil.\u20082000;79:53\u201359","DOI":"10.1097\/00002060-200001000-00012"},{"key":"2021120823344016900_R13","doi-asserted-by":"crossref","unstructured":"Hurvitz EA, Conti GE, Flansburg EL, Brown SH. Motor control testing of upper limb function after botulinum toxin injection: a case study. Arch Phys Med Rehabil.\u20082000;81:1408\u20131415","DOI":"10.1053\/apmr.2000.6293"},{"key":"2021120823344016900_R14","doi-asserted-by":"crossref","unstructured":"Wallen MA, O'Flaherty S J, Waugh MC. Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial. Arch Phys Med Rehabil.\u20082004;85:192\u2013200","DOI":"10.1016\/j.apmr.2003.05.008"},{"key":"2021120823344016900_R15","doi-asserted-by":"crossref","unstructured":"Wong V, Ng A, Sit P. Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy. J Child Neurol.\u20082002;17:138\u2013142","DOI":"10.1177\/088307380201700210"},{"key":"2021120823344016900_R16","doi-asserted-by":"crossref","unstructured":"Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity. Am J Phys Med Rehabil.\u20082003;82:284\u2013289","DOI":"10.1097\/01.PHM.0000056989.67763.07"},{"key":"2021120823344016900_R17","doi-asserted-by":"crossref","unstructured":"Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol.\u20081997;39:185\u2013193","DOI":"10.1111\/j.1469-8749.1997.tb07408.x"},{"key":"2021120823344016900_R18","unstructured":"Boyd RN, Bach TM, Morris C, Graham HK. A single blind randomized trial of botulinum toxin A and upper limb training in congenital hemiplegia - activity, participation and health related quality of life. Dev Med Child Neurol.\u20082003;45(suppl 96):10\u201311"},{"key":"2021120823344016900_R19","doi-asserted-by":"crossref","unstructured":"Lowe K, Novak I, Cusick A. Low-dose\/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy. Dev Med Child Neurol.\u20082006;48:170\u2013175","DOI":"10.1017\/S0012162206000387"},{"key":"2021120823344016900_R20","doi-asserted-by":"crossref","unstructured":"Speth LA, Leffers P, Janssen-Potten YJ, Vles JS. Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy. Dev Med Child Neurol.\u20082005;47:468\u2013473","DOI":"10.1017\/S0012162205000903"},{"key":"2021120823344016900_R21","doi-asserted-by":"crossref","unstructured":"Fehlings D, Rang M, Glazier J, Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy [comment]. J Pediatr.\u20082000;137:331\u2013337","DOI":"10.1067\/mpd.2000.108393"},{"key":"2021120823344016900_R22","doi-asserted-by":"crossref","unstructured":"Wasiak J, Hoare B, Wallen M. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy. Cochrane Database Syst Rev.\u20082004(4): CD003469","DOI":"10.1002\/14651858.CD003469.pub3"},{"key":"2021120823344016900_R23","doi-asserted-by":"crossref","unstructured":"Reeuwijk A, van Schie PE, Becher JG, Kwakkel G. Effects of botulinum toxin type A on upper limb function in children with cerebral palsy: a systematic review. Clin Rehabil.\u20082006;20:375\u2013387","DOI":"10.1191\/0269215506cr956oa"},{"key":"2021120823344016900_R24","unstructured":"Cerebral Palsy Register. Women's and Children's Hospital 2004 Annual Report. Adelaide, Australia: South Australian Clinical Genetics Service, Department of Genetic Medicine; 2005"},{"key":"2021120823344016900_R25","doi-asserted-by":"crossref","unstructured":"Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther.\u20081987;67:206\u2013207","DOI":"10.1093\/ptj\/67.2.206"},{"key":"2021120823344016900_R26","unstructured":"Gorman ProMed Pty Ltd. Electrical Low Frequency Stimulator: Model ELF-001. Victoria, Australia: Carnegie; 2002"},{"key":"2021120823344016900_R27","doi-asserted-by":"crossref","unstructured":"Chin TY, Nattrass GR, Selber P, Graham HK. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop.\u20082005;25:286\u2013291","DOI":"10.1097\/01.bpo.0000150819.72608.86"},{"key":"2021120823344016900_R28","doi-asserted-by":"crossref","unstructured":"Russman BS, Tilton A, Gormley ME Jr. Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve.\u20081997;6(suppl):S181\u2013S93","DOI":"10.1002\/(SICI)1097-4598(1997)6+<181::AID-MUS13>3.0.CO;2-9"},{"key":"2021120823344016900_R29","doi-asserted-by":"crossref","unstructured":"Gracies JM, Marosszeky JE, Renton R, Sandanam J, Gandevia SC, Burke D. Short-term effects of dynamic Lycra splints on upper limb in hemiplegic patients. Arch Phys Med Rehabil.\u20082000;81:1547\u20131555","DOI":"10.1053\/apmr.2000.16346"},{"key":"2021120823344016900_R30","unstructured":"Fisher AG. AMPS: Assessment of Motor and Process Skills Volume 1: Development, Standardisation, and Administration Manual. 5th ed. Ft Collins, CO: Three Star Press Inc; 2003"},{"key":"2021120823344016900_R31","doi-asserted-by":"crossref","unstructured":"Kottorp A, Bernspang B, Fisher AG. Validity of a performance assessment of activities of daily living for people with developmental disabilities. J Intellect Disabil Res.\u20082003;47:597\u2013605","DOI":"10.1046\/j.1365-2788.2003.00475.x"},{"key":"2021120823344016900_R32","doi-asserted-by":"crossref","unstructured":"Park S, Fisher AG, Velozo CA. Using the assessment of motor and process skills to compare occupational performance between clinic and home settings. Am J Occup Ther.\u20081994;48:697\u2013709","DOI":"10.5014\/ajot.48.8.697"},{"key":"2021120823344016900_R33","doi-asserted-by":"crossref","unstructured":"Kiresuk TJ, Sherman SA. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J.\u20081968;6:443\u2013753","DOI":"10.1007\/BF01530764"},{"key":"2021120823344016900_R34","doi-asserted-by":"crossref","unstructured":"McLaren C, Rodger S. Goal attainment scaling: clinical implications for paediatric occupational therapy practice. Aust Occup Ther J.\u20082003;50:216\u2013224","DOI":"10.1046\/j.1440-1630.2003.00379.x"},{"key":"2021120823344016900_R35","doi-asserted-by":"crossref","unstructured":"Daley BJ. Goal-attainment scaling: a method of evaluation, part one. J Contin Educ Nurs.\u20081987;18:200\u2013202","DOI":"10.3928\/0022-0124-19871101-07"},{"key":"2021120823344016900_R36","doi-asserted-by":"crossref","unstructured":"Harter S. Manual for the Self-Perception Profile for Children. Denver, CO: University of Denver; 1985","DOI":"10.1037\/t05338-000"},{"key":"2021120823344016900_R37","doi-asserted-by":"crossref","unstructured":"Harter S, Pike R. The pictorial scale of perceived competence and social acceptance for young children. Child Dev.\u20081984;55:1969\u20131982","DOI":"10.2307\/1129772"},{"key":"2021120823344016900_R38","doi-asserted-by":"crossref","unstructured":"Granleese J, Joseph S. Reliability of the Harter Self-Perception Profile for Children and predictors of global self-worth. J Genet Psychol.\u20081994;155:487\u2013492","DOI":"10.1080\/00221325.1994.9914796"},{"key":"2021120823344016900_R39","doi-asserted-by":"crossref","unstructured":"Pereda N, Forns M. Psychometric properties of the Spanish version of the self-perception profile for children. Percept Mot Skills.\u20082004;98:685\u2013699","DOI":"10.2466\/pms.98.2.685-699"},{"key":"2021120823344016900_R40","doi-asserted-by":"crossref","unstructured":"Haley SM, Coster WJ, Ludlow LH, Haltiwanger JT, Andrellos PJ. Pediatric Evaluation of Disability Inventory (PEDI). Boston, MA: New England Medical Center Hospitals Inc; 1992","DOI":"10.1037\/t08316-000"},{"key":"2021120823344016900_R41","doi-asserted-by":"crossref","unstructured":"Varni JW, Seid M, Kurtin PS. PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care.\u20082001;39:800\u2013812","DOI":"10.1097\/00005650-200108000-00006"},{"key":"2021120823344016900_R42","doi-asserted-by":"crossref","unstructured":"Brooks RB. Self-esteem during the school years. Its normal development and hazardous decline. Pediatr Clin North Am.\u20081992;39:537\u2013550","DOI":"10.1016\/S0031-3955(16)38343-2"},{"key":"2021120823344016900_R43","doi-asserted-by":"crossref","unstructured":"Michelsen SI, Uldall P, Kejs AM, Madsen M. Education and employment prospects in cerebral palsy. Dev Med Child Neurol.\u20082005;47:511\u2013517","DOI":"10.1017\/S0012162205001015"},{"key":"2021120823344016900_R44","doi-asserted-by":"crossref","unstructured":"Koman LA, Paterson Smith B, Balkrishnan R. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Paediatr Drugs.\u20082003;5:11\u201323","DOI":"10.2165\/00128072-200305010-00002"},{"key":"2021120823344016900_R45","doi-asserted-by":"crossref","unstructured":"Schwartz CE, Feinberg RG, Jilinskaia E, Applegate JC. An evaluation of a psychosocial intervention for survivors of childhood cancer: paradoxical effects of response shift over time. Psychooncology.\u20081999;8:344\u2013354","DOI":"10.1002\/(SICI)1099-1611(199907\/08)8:4<344::AID-PON399>3.0.CO;2-T"},{"key":"2021120823344016900_R46","doi-asserted-by":"crossref","unstructured":"De Civita M, Regier D, Alamgir AH, Anis AH, Fitzgerald MJ, Marra CA. Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics.\u20082005;23:659\u2013685","DOI":"10.2165\/00019053-200523070-00003"},{"key":"2021120823344016900_R47","doi-asserted-by":"crossref","unstructured":"Boyd RN, Hays RM. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Eur J Neurol.\u20082001;8:1\u201320","DOI":"10.1046\/j.1468-1331.2001.00034.x"},{"key":"2021120823344016900_R48","doi-asserted-by":"crossref","unstructured":"Flett PJ. Rehabilitation of spasticity and related problems in childhood cerebral palsy. J Paediatr Child Health.\u20082003;39:6\u201314","DOI":"10.1046\/j.1440-1754.2003.00082.x"},{"key":"2021120823344016900_R49","doi-asserted-by":"crossref","unstructured":"Lannin N, Scheinberg A, Clark K. AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections. Dev Med Child Neurol.\u20082006;48:533\u2013539","DOI":"10.1111\/j.1469-8749.2006.tb01309.x"},{"key":"2021120823344016900_R50","doi-asserted-by":"crossref","unstructured":"Cunningham BB, Gigler V, Wang K, et al. General anesthesia for pediatric dermatologic procedures: risks and complications. Arch Dermatol.\u20082005;141:573\u2013576","DOI":"10.1001\/archderm.141.5.573"},{"key":"2021120823344016900_R51","doi-asserted-by":"crossref","unstructured":"Davis EC, Barnes MP. Botulinum toxin and spasticity. J Neurol Neurosurg Psychiatry.\u20082000;69:143\u2013147","DOI":"10.1136\/jnnp.69.2.143"},{"key":"2021120823344016900_R52","doi-asserted-by":"crossref","unstructured":"To EW, Ahuja AT, Ho WS, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg.\u20082001;54:197\u2013200","DOI":"10.1054\/bjps.2000.3526"},{"key":"2021120823344016900_R53","doi-asserted-by":"crossref","unstructured":"Hadden KL, von Baeyer CL. Pain in children with cerebral palsy: common triggers and expressive behaviors. Pain.\u20082002;99:281\u2013288","DOI":"10.1016\/S0304-3959(02)00123-9"},{"key":"2021120823344016900_R54","doi-asserted-by":"crossref","unstructured":"Houlihan CM, O'Donnell M, Conaway M, Stevenson RD. Bodily pain and health-related quality of life in children with cerebral palsy. Dev Med Child Neurol.\u20082004;46:305\u2013310","DOI":"10.1111\/j.1469-8749.2004.tb00490.x"},{"key":"2021120823344016900_R55","doi-asserted-by":"crossref","unstructured":"Tervo RC, Symons F, Stout J, Novacheck T. Parental report of pain and associated limitations in ambulatory children with cerebral palsy. Arch Phys Med Rehabil.\u20082006;87:928\u2013934","DOI":"10.1016\/j.apmr.2006.02.023"},{"key":"2021120823344016900_R56","doi-asserted-by":"crossref","unstructured":"Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet.\u20082004;364:803\u2013811","DOI":"10.1016\/S0140-6736(04)16942-0"},{"key":"2021120823344016900_R57","doi-asserted-by":"crossref","unstructured":"Sutcliffe AG, Wong IC. Rational prescribing for children. Br Med J.\u20082006;332:1464\u20131465","DOI":"10.1136\/bmj.332.7556.1464"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/5\/e1149\/1119691\/zpe005070e1149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/5\/e1149\/1119691\/zpe005070e1149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T04:21:17Z","timestamp":1639023677000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/119\/5\/e1149\/70239\/Upper-Limb-Botulinum-Toxin-A-Injection-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,5,1]]},"published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-2425","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}